The clinical efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with Crohn's disease: A multicenter retrospective pilot study

被引：0

作者：

Ueno, Nobuhiro ^{[1
,2
,10
]}

Saito, Seisuke ^{[3
]}

Sato, Masahiro ^{[4
]}

Sugiyama, Yuya ^{[4
]}

Kobayashi, Yu ^{[4
]}

Murakami, Yuki ^{[4
]}

Sugimura, Kohjiro ^{[5
]}

Sasaki, Takahiro ^{[4
]}

Sakatani, Aki ^{[2
]}

Takahashi, Keitaro ^{[4
]}

Tanaka, Kazuyuki ^{[6
]}

Serikawa, Shinya ^{[7
]}

Ando, Katsuyoshi ^{[4
]}

Kashima, Shin ^{[4
]}

Muto, Momotaro ^{[8
]}

Inaba, Yuhei ^{[9
]}

Moriichi, Kentaro ^{[4
]}

Tanabe, Hiroki ^{[4
]}

Okumura, Toshikatsu ^{[4
]}

Fujiya, Mikihiro ^{[2
,4
]}

机构：

[1] Asahikawa Med Univ Hosp, Div Gen Med, Asahikawa, Hokkaido, Japan

[2] Asahikawa Med Univ, Dept Gastroenterol Sci, Asahikawa, Hokkaido, Japan

[3] Furano Hosp, Furano, Hokkaido, Japan

[4] Asahikawa Med Univ, Dept Internal Med, Div Gastroenterol, Asahikawa, Hokkaido, Japan

[5] Nakashibetsu Town Hosp, Nakashibetsu, Hokkaido, Japan

[6] Asahikawa Kosei Gen Hosp, Asahikawa, Hokkaido, Japan

[7] Nayoro City Gen Hosp, Nayoro, Hokkaido, Japan

[8] Engaru Kosei Gen Hosp, Engaru, Hokkaido, Japan

[9] Asahikawa City Hosp, Asahikawa, Hokkaido, Japan

[10] Asahikawa Med Univ Hosp, Div Gen Med, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2024年 / 28卷 / 03期

关键词：

biologics; clinical response; Crohn's disease; granulocyte and monocyte apheresis; loss of response;

D O I：

10.1111/1744-9987.14103

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: A remission induction therapy of granulocyte and monocyte adsorptive apheresis (GMA) was given to patients with Crohn's disease (CD). However, establishing an appropriate treatment strategy for GMA in patients with CD remains unclear.Methods: This study evaluated the clinical efficacy and subsequent clinical progression after GMA in patients with CD who underwent GMA in seven independent institutions in Japan from 2010 to 2023.Results: Sixteen patients were enrolled. The overall remission and response rates were 25.0% and 68.8%, respectively. All patients responding to GMA received biologics that were continuously used and 36.4% of patients remained on the same biologics 52 weeks after GMA. Notably, all patients who continued the same biologics had previously experienced a loss of response to biologics.Conclusion: GMA may exhibit effectiveness even in cases with refractory CD. Moreover, it represents a potential novel therapeutic option for refractory CD with loss of response to biologics.

引用

页码：442 / 452

页数：11

共 50 条

[11] Efficacy of granulocyte/monocyte apheresis for moderate to severe Crohn's disease
Eaden, James A.
Ford, Alexander Charles
GUT, 2013, 62 (04) : 653 - 653
[12] Adsorptive granulocyte and monocyte apheresis therapy for refractory Crohn's disease: An open multicentre prospective study
Fukuda, Y
Matsui, T
Suzuki, Y
Kanke, K
Matsumoto, T
Takazoe, M
Matsumoto, T
Motoya, S
Honma, T
Sawada, K
Fukunaga, K
Yao, T
Shimoyama, T
Hibi, T
GASTROENTEROLOGY, 2004, 126 (04) : A630 - A630
[13] Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis
Yanagisawa, Kazuki
Murakami, Minoru
Kondo, Yuya
Oguma, Shun
Kobayashi, Shun
Miyasaka, Hiroshi
Shinohara, Tomoaki
Tomori, Akihisa
Nakano, Yui
Furuhata, Shunichi
Ikezoe, Masaya
THERAPEUTIC APHERESIS AND DIALYSIS, 2019, 23 (03) : 217 - 223
[14] Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter study
Shimoyama, T
Sawada, K
Hiwatashi, N
Sawada, T
Matsueda, K
Munakata, A
Asakura, H
Tanaka, T
Kasukawa, R
Kimura, K
Suzuki, Y
Nagamachi, Y
Muto, T
Nagawa, H
Iizuka, B
Baba, S
Nasu, M
Kataoka, T
Kashiwagi, N
Saniabadi, AR
JOURNAL OF CLINICAL APHERESIS, 2001, 16 (01) : 1 - 9
[15] Efficacy of granulocyte and monocyte adsorption apheresis in chronic active Crohn's disease
Petermann, S
Ramlow, W
Liebe, S
Emmrich, J
GASTROENTEROLOGY, 2004, 126 (04) : A632 - A632
[16] Effectiveness of combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis in patients with crohn's disease
Ozeki, Keiji
Tanida, Satoshi
Mizoshita, Tsutomu
Tsukamoto, Hironobu
Katano, Takahito
Hayashi, Noriyuki
Tanaka, Mamoru
Nishiwaki, Hirotaka
Ebi, Masahide
Sawada, Takeshi
Mori, Yoshinori
Kubota, Eiji
Kataoka, Hiromi
Joh, Takashi
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 133 - 133
[17] Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease
Tanida, Satoshi
Mizoshita, Tsutomu
Ozeki, Keiji
Katano, Takahito
Tanaka, Mamoru
Nishie, Hirotada
Shimura, Takaya
Okamoto, Yasuyuki
Kubota, Eiji
Kataoka, Hiromi
Joh, Takashi
THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (03) : 295 - 300
[18] Concomitant pharmacologic medications influence the clinical outcomes of granulocyte and monocyte adsorptive apheresis in patients with ulcerative colitis: A multicenter retrospective cohort study
Ueno, Nobuhiro
Sugiyama, Yuya
Kobayashi, Yu
Murakami, Yuki
Iwama, Takuya
Sasaki, Takahiro
Kunogi, Takehito
Sakatani, Aki
Takahashi, Keitaro
Tanaka, Kazuyuki
Serikawa, Shinya
Ando, Katsuyoshi
Kashima, Shin
Muto, Momotaro
Inaba, Yuhei
Moriichi, Kentaro
Tanabe, Hiroki
Okumura, Toshikatsu
Fujiya, Mikihiro
JOURNAL OF CLINICAL APHERESIS, 2023, 38 (04) : 406 - 421
[19] A multicentre randomized controlled study of safety and efficacy of adsorptive granulocyte and monocyte apheresis in patients with active ulcerative colitis
Sawada, K
Hiwatashi, N
Munakata, A
Asakura, H
Suzuki, Y
Muto, T
Iizuka, B
Saniabadi, A
Shimoyama, T
GASTROENTEROLOGY, 2004, 126 (04) : A462 - A462
[20] Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: A prospective pilot study
Martin de Carpi, Javier
Vilar, Pere
Prieto, Gerardo
Garcia Novo, Maria Dolores
Ribes, Carmen
Varea, Vicente
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2008, 46 (04): : 386 - 391

← 1 2 3 4 5 →